Fig. 2
Physician-assessed overall clinical response to 6 months of IV belimumab treatment versus index date (FAS, N = 53). FAS full analysis set, IV intravenous
Fig. 2 | BMC Rheumatology
Physician-assessed overall clinical response to 6 months of IV belimumab treatment versus index date (FAS, N = 53). FAS full analysis set, IV intravenous